Treatment of Mycobacteriosis with Lung Destruction Using Long-Term Endobronchial Valve Implantation
Open Access
- 11 February 2022
- journal article
- research article
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 100 (1) , 49-54-54
Abstract
The article describes a case of effective treatment of fibrous cavernous pulmonary mycobacteriosis with the implantation of the endobronchial valve (valve bronchial block).Subjects and Methods. A 66-year-old man was diagnosed with fibrous cavernous pulmonary mycobacteriosis. M. chelonae was detected as a causative agent of the disease. At the time of diagnosis, the disease lasted for 12 months, the duration of treatment due to the erroneous diagnosis of tuberculosis made 6.5 months, the drug therapy of mycobacteriosis lasted for 11 months, and after development of the adverse event in the form of constant tinnitus, the patient interrupted the drug therapy. The patient received no drug therapy for 24 months before the implantation of the endobronchial valve.Result. The cure of mycobacteriosis and cavity healing were achieved after the implantation of the endobronchial valve. The endobronchial valve remained in the bronchus for 22 months. During this period and after the removal of the endobronchial valve, the patient did not take any medications, lived an active life and was managed on an outpatient basis.Keywords
This publication has 6 references indexed in Scilit:
- Endobronchial valve treatment for cavitary pulmonary diseases caused by non-tuberculosis mycobacteriaEuropean Respiratory Journal, 2019
- British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)BMJ Open Respiratory Research, 2017
- COMPARATIVE ANALYSIS OF METHODS FOR IDENTIFICATION OF NONTUBERCULOUS MYCOBACTERIA ISOLATED FROM CLINICAL MATERIALRussian Journal of Infection and Immunity, 2017
- Treatment of Non-Tuberculous Mycobacterial Lung DiseaseCurrent Treatment Options in Infectious Diseases, 2016
- Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung diseaseBMC Infectious Diseases, 2015
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007